BioRestorative Therapies, Inc. (BRTX)
1.62
+0.12
(+8.00%)
USD |
NASDAQ |
Oct 23, 16:00
1.59
-0.03
(-1.85%)
After-Hours: 20:00
BioRestorative Therapies Enterprise Value : -1.494M for Oct. 23, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 23, 2026 | -1.494M |
| October 22, 2026 | -1.647M |
| October 21, 2026 | -1.608M |
| October 20, 2026 | -1.570M |
| October 19, 2026 | -1.519M |
| October 16, 2026 | -1.596M |
| October 15, 2026 | -1.698M |
| October 14, 2026 | -1.647M |
| October 13, 2026 | -1.532M |
| October 12, 2026 | -1.328M |
| October 09, 2026 | -1.124M |
| October 08, 2026 | -1.150M |
| October 07, 2026 | -0.704M |
| October 06, 2026 | -0.6657M |
| October 05, 2026 | -0.704M |
| October 02, 2026 | -0.8314M |
| October 01, 2026 | -0.6657M |
| September 30, 2026 | -0.5893M |
| September 29, 2026 | -0.5893M |
| September 28, 2026 | -0.6148M |
| September 25, 2026 | -0.3091M |
| September 24, 2026 | -0.36M |
| September 23, 2026 | -0.2454M |
| September 22, 2026 | -0.3091M |
| September 21, 2026 | -0.1052M |
| Date | Value |
|---|---|
| September 18, 2026 | -0.1307M |
| September 17, 2026 | -0.1753M |
| September 16, 2026 | -0.3091M |
| September 15, 2026 | -0.1944M |
| September 14, 2026 | -0.118M |
| September 11, 2026 | -0.1562M |
| September 10, 2026 | -0.0415M |
| September 09, 2026 | -0.067M |
| September 08, 2026 | 0.013M |
| September 04, 2026 | 0.2132M |
| September 03, 2026 | 0.1037M |
| September 02, 2026 | 1.581M |
| September 01, 2026 | 1.494M |
| August 31, 2026 | 1.599M |
| August 28, 2026 | 1.515M |
| August 27, 2026 | 1.691M |
| August 26, 2026 | 1.969M |
| August 25, 2026 | 2.111M |
| August 24, 2026 | 1.874M |
| August 21, 2026 | 1.928M |
| August 20, 2026 | 2.063M |
| August 19, 2026 | 1.877M |
| August 18, 2026 | 1.869M |
| August 17, 2026 | 2.048M |
| August 14, 2026 | 2.198M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Myriad Genetics, Inc. | 651.69M |
| CareDx, Inc. | 3.209B |
| Natera, Inc. | 57.16B |
| Exagen, Inc. | 178.95M |
| Sera Prognostics, Inc. | 36.62M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -2.154M |
| Revenue (Quarterly) | 0.0232M |
| Total Expenses (Quarterly) | 2.178M |
| EPS Diluted (Quarterly) | -2.431 |
| Gross Profit Margin (Quarterly) | -157.8% |
| Profit Margin (Quarterly) | -9.29K% |
| Earnings Yield | -1.38K% |
| Normalized Earnings Yield | -1612.54 |